small

Documents about small

• Molecular Analysis and Treatment Options of SCLC#238128ClinicalTrials.gov
• Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer#146473ClinicalTrials.gov
• Durvalumab and Lurbinectedin for the Treatment of Relapsed or Refractory Small Cell Lung Cancer#208427ClinicalTrials.gov
• Causes Associated With Small Fiber Neuropathy (SFN).#148679ClinicalTrials.gov
• Characterization of the virus-host RNA-RNA interactome across important human pathogenic RNA viruses#187821PLOS
• Cyber Essentials: A Guide for Small Businesses#2429CISA
• Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery#28559ClinicalTrials.gov
• DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer#125821ClinicalTrials.gov
• Small intestinal microbiome, the underrated maestro of SIMO disease#193054HAL (France)
• The use of financial statements for decision making by small firms#168014Iowa State University Digital Repository
• Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung Cancer#123464ClinicalTrials.gov
• The Political Economy of Small Arms Proliferation in the Greater Horn of Africa#126668Zenodo (CERN)
• Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer#143570ClinicalTrials.gov
• Small business and social media marketing: What role does ethics play?#243632DigitalCommons@Kennesaw State University
• Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC#184838ClinicalTrials.gov
• Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer#18606ClinicalTrials.gov
• A Biomarker Screening Protocol for Participants With Solid Tumors#184830ClinicalTrials.gov
• Informing small business development: The impact of marketing led strategic development in a small firm#234828Durham e-Theses
• DIAGNOSIS, TREATMENT AND OUTCOME OF LUNG CANCER PATIENTS#245497ClinicalTrials.gov
• Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer#146435ClinicalTrials.gov
• Study of Pembrolizumab (MK-3475) Monotherapy in Advanced Solid Tumors and Pembrolizumab Combination Therapy in Advanced Non-small Cell Lung Cancer/ Extensive-disease Small Cell Lung Cancer (MK-3475-011/KEYNOTE-011)#152389ClinicalTrials.gov
• Autologous Tumor DRibble Vaccine in Patients With Non-Small Cell Lung Cancer#141081ClinicalTrials.gov
• AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer#141096ClinicalTrials.gov
• Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer#143782ClinicalTrials.gov
• Neoadjuvant Therapy in Resectable Non-Small Cell Lung Cancer Stages IIB-IIIB#195298ClinicalTrials.gov
• Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC)#238101ClinicalTrials.gov
• Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung Cancer#18592ClinicalTrials.gov
• Neo-Adjuvant Immunotherapy With Nivolumab for Non Small Cell Lung Cancer Patients#18603ClinicalTrials.gov
• Panomic Approach to Immune-Connected Assays in Small Cell Lung Cancer#67899ClinicalTrials.gov
• Neoadjuvant Anti PD-1 Immunotherapy in Resectable Non-small Cell Lung Cancer#121367ClinicalTrials.gov
• MIDRIXNEO-LUNG Dendritic Cell Vaccine in Patients With Non-small Cell Lung Cancer#162482ClinicalTrials.gov
• Comprehensive Geriatric Assessment in Elderly Non-Small Cell Lung Cancer Patients#217020ClinicalTrials.gov
• Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer#238093ClinicalTrials.gov
• Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)#201767ClinicalTrials.gov
• Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)#172370ClinicalTrials.gov
• MIDRIX4-LUNG Dendritic Cell Vaccine in Patients With Metastatic Non-small Cell Lung Cancer#195332ClinicalTrials.gov
• A Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer.#201621ClinicalTrials.gov
• Artificial Intelligence for Help Non-Small Cell Lung Cancer: Measure Cancer Biology and Treatment Response Via Imaging#222408ClinicalTrials.gov
• Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors#121363ClinicalTrials.gov
• Small Is Beautiful#18195Open Library
• Small Singular Regions of Spacetime#90885PhilArchive
• Small Evils and Live Options#103581PhilArchive
• The Practicality of Practical Inference#110717PhilArchive
• Split-course Hypofractionated Radiotherapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer#67905ClinicalTrials.gov
• PD-1 Inhibitors Consolidation in Extensive-stage Small Cell Lung Cancer#127586ClinicalTrials.gov
• Greater Newark STEM Ecosystem - 2026 Convening - Small Group Outcomes & Action Plan#168743Digital Commons @ NJIT
• Small area estimation for business surveys: a comparison of transformation-based unit level models#185367IRIS
• Ipilimumab and Nivolumab in Patients With Anti-PD-1-axis Therapy-resistant Advanced Non-small Cell Lung Cancer.#143554ClinicalTrials.gov
• Blood-brain Barrier Quantification in Cerebral Small Vessel Disease#148596ClinicalTrials.gov
• A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer#154718ClinicalTrials.gov

Related topics